SEC Form 4/A · accession 0000950138-19-000088
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Frank Scholz
Officer — EVP & Chf Ops & Dig Innov Off
Period of report
Jan 3, 2019
Accepted (ET)
Feb 15, 2019 · 8:09 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 3, 2019 | F | 886 | $16.14 | D | 73,076 | D | |
| Ordianry SharesF1 | Jan 4, 2019 | F | 498 | $17.21 | D | 72,578 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed due to an administrative error in tax withholding calculations.